Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 70 years old (inclusive), of any sex
- People who have at least one tumour area that can be assessed, with a confirmed diagnosis of glioblastoma (a type of brain tumour classified as WHO Grade IV), and scan results suggesting the tumour has continued to grow or come back after treatment
- People whose physical functioning is rated at 60% or above on a standard medical scale that measures ability to carry out daily activities (called the Karnofsky Performance Status)
- People whose life expectancy is estimated to be more than 4 weeks
- People who finished radiation therapy or other cancer treatments (such as temozolomide, bevacizumab, or similar medicines) at least 4 weeks before joining, and whose side effects from those treatments have mostly resolved to a mild level or lower (with the exception of things like hair loss)
- People who are able to undergo an MRI scan with contrast dye
- People whose blood test results show that the liver, kidneys, bone marrow, and blood clotting are all working within acceptable ranges (confirm specific values with the trial site)
- People with no known significant inherited (hereditary) diseases
- People whose heart is functioning normally, with a pumping efficiency measurement above 55%
- People with no bleeding or blood clotting disorders
- People with no signs of active bacterial, fungal, or viral infection in the blood, and no signs of brain/spinal fluid infection (meningitis), within 48 hours before receiving the trial treatment
- Women who are able to become pregnant must have a negative pregnancy test within 7 days before starting treatment, and must agree to use contraception during the trial and for 6 months after the last treatment session; any suspected pregnancy during the trial must be reported to the treating doctor immediately
- People who have read, understood, and signed a written consent form agreeing to take part
Who may not be able to join:
- People with an active hepatitis B or C infection, HIV, or any other untreated active infection
- People who are pregnant or currently breastfeeding
- People with organ failure
- People with a long-term (chronic) condition that requires ongoing treatment with immune-suppressing or hormonal medicines
- People with a known allergy to immunotherapy or related cell-based treatments
- People with a serious ongoing illness that is not well controlled
- People with a psychiatric condition or personal circumstances that may make it difficult to follow the trial requirements
- People who have previously had an organ transplant or who are currently waiting for one
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (+86)-135-1108-7060
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events (AEs); Incidence of Dose-Limiting Toxicities (DLTs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.